#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pouchitis Kaposi's sarcoma Autologous haematopoietic stem cell transplant Univentricular heart Penile cancer Ornithine transcarbamoylase deficiency Erythema Pleomorphic liposarcoma Cervix carcinoma recurrent Epilepsy with myoclonic-atonic seizures Transferrin decreased Hereditary ataxia Arteriosclerosis Albright's disease Nephropathy More trials…

    Learn about Rare Diseases

    Chondrosarcoma – Life with Disease Nephroblastoma – Treatment Glycogen storage disease type I Undifferentiated sarcoma SAPHO syndrome – Diagnostics Leiomyosarcoma metastatic – Diagnostics Lymphatic malformation – Basic Information Splenic marginal zone lymphoma – Diagnostics Kearns-Sayre syndrome – Trials in Disease Breast angiosarcoma metastatic – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bempikibart Tamsulosin Hydrochloride Gsk6097608 Lisaftoclax Abatacept Avalotcagene Ontaparvovec Mepolizumab Etavopivat POTASSIUM HYDROXIDE Pomalidomide Taldefgrobep Alfa Tolinapant Lactate Maralixibat Chloride Ergocalciferol Bp Befiradol (18F) Dexamethasone Ph. Eur. Fidanacogene Elaparvovec Sonelokimab Amphotericin B Idecabtagene Vicleucel More therapies…

    Learn about Your Condition

    Mitochondrial myopathy Fallopian tube cancer stage IV Colon cancer Cytokine release syndrome Apheresis Mucopolysaccharidosis III Mast cell activation syndrome Syphilis Gallbladder cancer Supranuclear palsy Sexual dysfunction Pelizaeus-Merzbacher disease Nasopharyngeal cancer Salivary gland cancer Usher's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Long-Term Safety of GTX-102 for Patients with Angelman Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Angelman’s syndrome
    Investigated Drugs:
    • Calcium Chloride
    • DISODIUM PHOSPHATE
    • Glucose, Anhydrous
    France Germany Spain

  • Study on HPV Vaccine Timing for Patients After Stem Cell Transplantation Using Gardasil 9

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Allogenic stem cell transplantation
    Investigated Drugs:
    • Human Papillomavirus Type 11 L1 Protein
    • Human Papillomavirus Type 16 L1 Protein
    • Human Papillomavirus Type 18 L1 Protein
    Sweden

  • Study on Encorafenib and Cetuximab for Patients with BRAF V600E-Mutated Localized Colon or Upper Rectum Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    • Rectal cancer
    Investigated Drugs:
    • Cetuximab
    • Encorafenib
    France

  • Long-term Safety Study of AUTO4 and Rituximab in Patients with Potential Malignancy Treated with Autologous CAR T Cell Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    • Systemic lupus erythematosus
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Auto4
    • Autologous Enriched T Cells Retrovirally Transduced To Express Two Chimeric Antigen Receptors Targeting Cd19 And Cd22
    • Rituximab
    Spain

  • Study of ART6043, Olaparib, and Niraparib in Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Art6043
    • Olaparib
    Spain

  • Study on the Effects of Botulinum Toxin Type A and a Drug Combination on Rectal Function in Patients with Fecal Incontinence

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anal incontinence
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Macrogol 3350
    • Sodium Ascorbate
    France
Previous Page
1 … 314 315 316 317 318 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!